 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| Concentration | Treated Time | Description | References | |
| COS-7 cells | 3 µM | 30 minutes | To evaluate the antagonistic effect of F16357 on TFLLR-NH2-induced G-protein activation. Results showed that F16357 antagonized 3 μM TFLLR-NH2-induced [35S]-GTPγS binding with pKb values of 6.04. | Br J Pharmacol. 2016 Jul;173(14):2224-36 | 
| COS-7 cells | 1 µM | 5 hours | To evaluate the antagonistic effect of F16357 on TFLLR-NH2-induced SRE-luciferase activity. Results showed that F16357 antagonized 1 μM TFLLR-NH2-induced luminescence with a pKb value of 5.49. | Br J Pharmacol. 2016 Jul;173(14):2224-36 | 
| Administration | Dosage | Frequency | Description | References | ||
| Rat | Rat hindpaw edema model | Intraplantar injection | 0.01 – 0.1 mmol per paw | Single injection, evaluated after 15 minutes | To evaluate the effect of TFLLR-NH2 on vascular permeability and edema formation in rat hindpaw, showing a dose-dependent increase in vascular permeability and edema formation | Br J Pharmacol. 1999 Apr;126(8):1856-62 | 
| Mice | H1N1 influenza virus infection model | Intranasal administration | 50 μM | Administered on days 0, 2, and 3 post-infection | PAR1 activation increased weight loss and mortality in H1N1-infected mice, indicating PAR1 plays a significant role in influenza virus pathogenicity. | J Clin Invest. 2013 Jan;123(1):206-14 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 1.31mL 0.26mL 0.13mL | 6.56mL 1.31mL 0.66mL | 13.13mL 2.63mL 1.31mL | |
| CAS号 | 1313730-19-6 | 
| 分子式 | C33H54F3N9O8 | 
| 分子量 | 761.83 | 
| SMILES Code | [C@@H](NC(=O)[C@@H](N)[C@H](O)C)(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N)CCCNC(N)=N)CC1C=CC=CC=1.C(F)(F)(F)C(=O)O | 
| MDL No. | MFCD05663482 | 
| 别名 | TFLLR-NH2 trifluoroacetate salt | 
| 运输 | 蓝冰 | 
| InChI Key | QVNWOGSDGQDGHP-MKVNCOEFSA-N | 
| Pubchem ID | 71311619 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C | 
| 溶解方案 | DMSO: 105 mg/mL(137.83 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(131.26 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1